清胰解毒汤鼻饲联合连续性血液净化治疗瘀毒互结型重症急性胰腺炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R576

基金项目:

浙江省中医药科技计划项目(2024ZL660)


Clinical Study on Qingyi Jiedu Decoction by Nasal Feeding Combined with Continuous Blood Purification for Severe Acute Pancreatitis of Stasis and Toxin Accumulation Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察在常规对症疗法基础上采用清胰解毒汤鼻饲联合连续性血液净化(CBP)治疗瘀毒互结 型重症急性胰腺炎的临床效果。方法:受试对象为浙江中医药大学附属杭州市中医院2022年5月—2024年5月 收治的108例瘀毒互结型SAP患者,按随机数字表法分为研究组、对照组各54例。2组均予常规对症治疗,对 照组采取CBP治疗,研究组予清胰解毒汤鼻饲联合CBP治疗,2组均治疗2周。于治疗前后评定中医证候评分、 急性生理和慢性健康评分(APACHE-Ⅱ评分), 检测炎症因子[高敏C-反应蛋白(hs-CRP)、降钙素 原(PCT)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]、肠道黏膜屏障功能指标[内毒素(ETX)、 二胺氧化酶(DAO)、D-乳酸(D-LAC)]、胰腺外分泌功能指标[淀粉酶(AMY)、脂肪酶(LPS)] 水平。 比较2组的临床疗效。结果:治疗后,研究组总有效率92.31%(48/52),高于对照组78.43%(40/51),差异有 统计学意义(P<0.05)。2组中医证候积分、APACHE-Ⅱ评分均较治疗前下降(P<0.05);研究组中医证候积 分、APACHE-Ⅱ评分均低于对照组(P<0.05)。2 组血清hs-CRP、PCT、IL-6、TNF-α、ETX、DAO、 D-LAC、AMY、LPS水平均较治疗前下降(P<0.05),研究组以上9项指标水平均低于对照组(P<0.05)。结 论:在现代医学常规对症疗法基础上采用清胰解毒汤鼻饲联合CBP治疗瘀毒互结型重症急性胰腺炎能提高疗 效,对缓解临床症状、减轻病情、改善肠道黏膜屏障功能及胰腺外分泌功能有积极作用。

    Abstract:

    Abstract:Objective:To observe the clinical effect of using Qingyi Jiedu Decoction by nasal feeding combined with continuous blood purification (CBP) on the basis of conventional symptomatic therapy for the treatment of severe acute pancreatitis (SAP) of stasis and toxin accumulation type. Methods:The subjects were 108 SAP patients of stasis and toxin accumulation type admitted to Hangzhou TCM Hospital of Zhejiang Chinese Medical University from May 2022 to May 2024. They were divided into the study group and the control group using the random number table method, with 54 patients in each group. Both groups received routine symptomatic treatment;the control group received CBP, and the study group received Qingyi Jiedu Decoction by nasal feeding combined with CBP. Both groups were treated for two weeks. The following indexes were evaluated before and after treatment: the traditional Chinese medicine syndrome scores,Acute Physiology and Chronic Health Evaluation (APACHE-Ⅱ scores),serum inflammatory factors [high-sensitivity C-reactive protein (hs-CRP), procalcitonin (PCT), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF- α)], intestinal mucosal barrier function indicators [endotoxin(ETX), diamine oxidase (DAO), Dlactate (D-LAC)], and pancreatic exocrine function indicators [amylase (AMY), lipase (LPS)] levels. The clinical effects in the two groups were compared as well. Results:After treatment,the total effective rate was 92.31%(48/52) in the study group, higher than that in the control group (78.43%, 40/51), the difference being significant (P< 0.05). The traditional Chinese medicine syndrome scores and APACHE-Ⅱ scores in both groups were decreased when compared with those before treatment (P<0.05);the traditional Chinese medicine syndrome scores and APACHE-Ⅱ scores in the study group were lower than those in the control group (P<0.05). The levels of hs-CRP,PCT,IL-6, TNF-α,ETX,DAO,D-LAC,AMY,and LPS in both groups of serum were decreased when compared with those before treatment (P<0.05), and the above nine levels in the study group were lower than those in the control group (P<0.05). Conclusion:On the basis of conventional symptomatic therapy,the use of Qingyi Jiedu Decoction by nasal feeding combined with CBP can improve the effect of treating severe acute pancreatitis of stasis and toxin accumulation type. It has a positive effect on relieving clinical symptoms, alleviating the condition, improving intestinal mucosal barrier function and pancreatic exocrine function.

    参考文献
    相似文献
    引证文献
引用本文

周建明,张美齐,王亚坤,吴微华,俞振飞.清胰解毒汤鼻饲联合连续性血液净化治疗瘀毒互结型重症急性胰腺炎临床研究[J].新中医,2025,57(14):84-90

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-07-26
  • 出版日期:
文章二维码